Is naratriptan classified as a controlled substance?
Naratriptan is not a controlled substance under U.S. federal law. It is a prescription-only medicine, but it is not listed on the federal Controlled Substances Act schedules.
Why it’s not considered a “controlled” drug
Controlled substances are typically drugs that have been placed into schedules due to factors like high abuse potential and recognized risks of misuse. Naratriptan is used for migraine treatment and is regulated as a standard prescription medication rather than through controlled-substance scheduling.
Does any country regulate naratriptan differently?
Regulation varies by country, but the key U.S. question is whether it appears on the Controlled Substances Act schedules. For U.S. patients and prescribers, naratriptan is not scheduled, so state “controlled substance” rules tied to federal scheduling generally do not apply.
What to check if you need certainty for your location
If you’re in the U.S., you can confirm by checking whether the specific product (brand/generic) appears on federal controlled-substance schedules. If you’re outside the U.S., your country’s medicines agency or national drug scheduling list is the right reference.
Sources
No sources were provided in the prompt, so I can’t cite a specific registry (e.g., DEA scheduling list) here.